Voyager Therapeutics Inc. (VYGR)
3.42
0.05 (1.48%)
At close: Apr 02, 2025, 3:59 PM
3.38
-1.17%
After-hours: Apr 02, 2025, 07:55 PM EDT
Voyager Therapeutics Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
| Cash & Equivalents | 71.37M | 68.8M | 98.96M | 117.43M | 104.44M | 86.04M | 46.86M | 31.53M | 36.64M | 31.31M | 7.04M | 135K |
| Short-Term Investments | 195.32M | 162.07M | 19.89M | 15.11M | 76.7M | 195.49M | 108.95M | 137.52M | 137.78M | 163.03M | n/a | n/a |
| Long-Term Investments | n/a | 1.59M | 1.51M | 1.78M | 1.78M | 1.92M | 628K | 1.1M | 1.36M | 30.01M | n/a | n/a |
| Other Long-Term Assets | 68.58M | n/a | n/a | n/a | 537K | 1.72M | 1.15M | 1.3M | 1.53M | 321K | 335K | 14K |
| Receivables | 1.5M | 84.45M | 639K | 748K | 8.01M | 18.7M | 201K | n/a | 2.3M | 411K | n/a | n/a |
| Inventory | n/a | n/a | 779K | 1.71M | 6.95M | 2.2M | 5.11M | 1.85M | 1.52M | -29.24M | n/a | n/a |
| Other Current Assets | 8.62M | 2.63M | 4.23M | 1.7M | 5.39M | 1.95M | 1.36M | 2.22M | 430K | 382K | 1.3M | n/a |
| Total Current Assets | 276.81M | 319.68M | 124.5M | 136.7M | 197.77M | 304.66M | 162.48M | 171.79M | 178.79M | 195.89M | 8.36M | 135K |
| Property-Plant & Equipment | 47.66M | 30M | 33.34M | 55.38M | 61.5M | 46.46M | 12.77M | 10.28M | 7.89M | 3.23M | 2.8M | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 116.24M | 31.6M | 34.86M | 57.16M | 63.81M | 50.1M | 14.55M | 12.69M | 10.78M | 33.56M | 3.14M | 14K |
| Total Assets | 393.05M | 351.28M | 159.36M | 193.85M | 261.58M | 354.76M | 177.03M | 184.48M | 189.57M | 229.46M | 11.5M | 149K |
| Account Payables | 4M | 1.6M | 2.57M | 574K | 634K | 4.07M | 1.04M | 1.02M | 550K | 612K | 1.55M | 950K |
| Deferred Revenue | 24.39M | 42.88M | 65.83M | 42.1M | 7.73M | 47.23M | 20.85M | 3.38M | 6.76M | 19.59M | n/a | n/a |
| Short-Term Debt | 7.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.93M |
| Other Current Liabilities | 6.75M | 10.21M | 3.26M | 5.93M | 8.35M | 15.78M | 6.01M | 8.11M | 4.09M | 2.39M | 552K | 15K |
| Total Current Liabilities | 49.79M | 64.51M | 72.59M | 50.98M | 26.77M | 76.01M | 31.67M | 15.9M | 13.8M | 23.93M | 2.47M | 3.98M |
| Long-Term Debt | 36.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.3M | n/a |
| Other Long-Term Liabilities | 7M | 1M | 1M | 1M | 1M | 1M | 6.71M | 6.35M | 5.02M | 1.06M | 1.57M | n/a |
| Total Long-Term Liabilities | 43.5M | 50.45M | 27.75M | 47.82M | 80.5M | 179.24M | 98.91M | 34.53M | 39.84M | 36.45M | 7.87M | 3.88M |
| Total Liabilities | 93.29M | 114.96M | 100.34M | 98.8M | 107.26M | 255.25M | 130.58M | 50.43M | 53.64M | 60.38M | 10.35M | 3.98M |
| Total Debt | 43.73M | 20.29M | 23.13M | 44.18M | 47.61M | 34.17M | n/a | n/a | n/a | n/a | 6.3M | 2.93M |
| Common Stock | 55K | 44K | 38K | 38K | 37K | 37K | 32K | 32K | 26K | 25K | 1K | n/a |
| Retained Earnings | -326.18M | -261.18M | -393.51M | -347.1M | -275.91M | -312.65M | -269.05M | -160.71M | -90.02M | -49.82M | -20.83M | -3.83M |
| Comprehensive Income | -407K | -48K | -219K | -138K | -134K | -104K | -133K | -287K | -52K | -251K | -21.98M | n/a |
| Shareholders Equity | 299.76M | 236.32M | 59.02M | 95.06M | 154.32M | 99.51M | 46.45M | 134.05M | 135.92M | 169.07M | 1.15M | -3.83M |
| Total Investments | 195.32M | 163.67M | 19.89M | 15.11M | 76.7M | 197.41M | 109.58M | 138.62M | 139.14M | 193.04M | n/a | n/a |